CIPO Patents = 1

EPO Patents = 2

Forward Citations = 5

Loading Chart...

2 inventors (with patents filed for the assignee):

Darren James Kelly (4 out of 9 patents)

David Stapleton (4 out of 6 patents)

4 patents: Sort by Forward Citations

1. 11583535 - Methods of treating eye diseases associated with inflammation and vascular proliferation (2023-02-21),

2. 10786510 - Methods of treating eye diseases associated with inflammation and vascular proliferation (2020-09-29),

3. 10695353 - Methods of treating eye diseases associated with inflammation and vascular proliferation (2020-06-30),

4. 9839640 - Methods of treating eye diseases associated with inflammation and vascular proliferation (2017-12-12),

Company Overview

Occurx Pty Ltd is a technology company specializing in predictive analytics and data visualization solutions. Our innovative tools help businesses make informed decisions by analyzing large datasets and presenting insights in a user-friendly format. With a focus on accuracy and efficiency, Occurx is dedicated to providing cutting-edge solutions that drive success for our clients.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#63 in Melbourne

#1,030 in Australia

Melbourne, Australia

Occurx Pty Ltd

Forward Citations = 5

2 inventors:

Darren James Kelly (4 out of 9 patents)

David Stapleton (4 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Occurx Pty Ltd. Retrieved from https://idiyas.com/company/occurx-pty

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]